Patents Assigned to MagnaMedics GmbH
  • Publication number: 20120053572
    Abstract: Instruments coated with ferrofluids for invasive medicine can be imaged by magnetic resonance imaging (MRI) with high quality.
    Type: Application
    Filed: January 27, 2009
    Publication date: March 1, 2012
    Applicant: MagnaMedics GmbH
    Inventors: Viorel Rusu, Paul Borm
  • Patent number: 7919333
    Abstract: The invention relates to spherical and magnetic silicagel particles which are provided with an increased surface by incorporating SiO2 colloids and produced by a method for inverse dispersion cross-linking of silica sols. The addition of certain metallic oxides to said silica sols and a subsequent tempering make it possible to obtain silicagel particles which exhibit increased nucleic acid binding properties and are used for separating a nucleic acid and isolating biomolecules.
    Type: Grant
    Filed: November 23, 2004
    Date of Patent: April 5, 2011
    Assignee: MagnaMedics GmbH
    Inventor: Detlef Müller-Schulte
  • Publication number: 20070148437
    Abstract: The invention relates to biocompatible, thermosensitive polymers that can be heated, with the aid of a high-frequency magnetic alternating field, by encapsulating magnetic and/or metallic colloids or magnetic nanoparticles. As a result of the inductive heating of the polymer matrix, physical structure changes are triggered in the polymer matrix that lead to the bioactive substances encapsulated in the matrix being released within a short period of time. This “stimulus-response” principle is employed for the production of controllable drug depots, contrast-intensifying media for NMR diagnostics or manipulable micro-tools, as media for blocking blood vessels and as controllable porogens in the production of membranes.
    Type: Application
    Filed: October 22, 2004
    Publication date: June 28, 2007
    Applicant: MagnaMedics GmbH
    Inventor: Detlef Müller-Schulte
  • Publication number: 20070087385
    Abstract: The invention relates to spherical and magnetic silicagel particles which are provided with an increased surface by incorporating SiO2 colloids and produced by a method for inverse dispersion cross-linking of silica sols. The addition of certain metallic oxides to said silica sols and a subsequent tempering make it possible to obtain silicagel particles which exhibit increased nucleic acid binding properties and are used for separating a nucleic acid and isolating biomolecules.
    Type: Application
    Filed: November 23, 2004
    Publication date: April 19, 2007
    Applicant: MagnaMedics GmbH
    Inventor: Detlef Müller-Schulte